Dear Democracy Now! Visitor: We are an independent, ad-free daily news program that serves millions of viewers and listeners each month. In this US election year, Democracy Now! is more important than ever. For 20 years, we’ve put a spotlight on corporate and government abuses of power. We lift up the stories of ordinary people working to make change in extraordinary times. We do all of this with just a fraction of the budget and staff of a commercial news show. We do it without ads, corporate sponsorship or government funding. How is this possible? Only with your support. A generous funder will match your donation dollar for dollar if you donate right now. That means when you give $10, your donation will be worth $20. Pretty exciting, right? So, if you've been waiting to make your contribution to Democracy Now!, today is your day. It takes just a couple of minutes to make sure that Democracy Now! is there for you every day.

Your Donation: $

Cancer Patients Who Protested TPP Arraigned in D.C. Court

February 26, 2016
Headlines
Hdls12 tpp

In Washington, D.C., cancer patients Zahara Heckscher and Hannah Lyon were arraigned Thursday on charges stemming from their February protest against the Trans-Pacific Partnership, known as the TPP, and its so-called death sentence clause, which would extend drug company monopolies on medicines. Zahara Heckscher spoke after their arraignment.

Zahara Heckscher: "We’re going to keep fighting against the TPP, keep fighting to get the word out about the danger of the TPP for people with cancer and people who need access to medicines in the U.S. and around the world. So we’re going to keep fighting, even though we have to deal with the criminal justice system. That’s OK. We’re going to keep the struggle going."

Topics:


The original content of this program is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 United States License. Please attribute legal copies of this work to democracynow.org. Some of the work(s) that this program incorporates, however, may be separately licensed. For further information or additional permissions, contact us.